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ABSTRACT OF THESIS

THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN LEUKEMIA TRAFFICKING

Vascular endothelial growth factor (VEGF) is a signaling protein involved in inducing and
regulating endothelial cell proliferation and function (Duffy et al 2000). VEGF is also involved in
cancer progression, as it induces vascular permeability and promotes angiogenesis to tumor
laden areas, giving cancer cells critical oxygen and nutrients (Hoeppner et al.,2012. Studies
indicate VEGF prevents lymphoblast apoptosis, which may contribute to leukemia formation and
enable the proliferation of leukemic cells (Duffy et al 2000). Ongoing research seeks to further
examine VEGF in leukemia, using a rag2:GFP-Myc expressing transgenic zebrafish as the animal
model of T-cell Acute Lymphoblastic Leukemia (T-ALL). Recent findings have concluded a
relationship between VEGF expression in leukemic fish remodels the microenvironment leading
to cell migration, but not through vascular restructuring, as a means to upregulate leukemic
expression.
KEYWORDS: Leukemia Trafficking, Lymphocyte Migration, Vascular Endothelial Growth Factor
(VEGF), Zebrafish T-ALL, Acute Lymphoblastic Leukemia
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Introduction
Zebrafish as a Leukemia Model
Acute lymphoblastic leukemia (ALL) is a cancer prone to occurring in children, but can
recur or even occur for the first time in adults, particularly the elderly, with a poorer prognosis
in later years (Terwilliger et al., 2017). In vivo models of human cancer in zebrafish (Danio rerio)
are a growing field of study to help inform treatment and diagnosis of the disease. Zebrafish are
small, reproduce quickly and are 71% of human proteins have a direct zebrafish homology
(Stolotov et al, 2008). They can be housed and fed inexpensively compared to rodents and can
be genetically modified in the germline in order to conduct experiments. Zebrafish embryos are
translucent, and development can be wholly observed ex vivo, since they are not mammals.
Organ development occurs within 3 days post fertilization (dpf) can be observed without
sacrificing the animal (Baeten et al., 2018). They lay clutches upwards of 30 eggs at a time,
which helps dull genetic diversity when conducting large scale experiments.
Mutant lines have been generated to lack pigment, which enables fluorescence
microscopy of interior anatomy. The zebrafish can be viewed live, with all its organ systems
intact and with no need for sectioning in order to view deeper tissue. This saves both money
and time, by negating the necessity for sectioning tools and fixative and the slow application of
sections to slides. Furthermore, zebrafish can be injected with human transgenes and produce
human proteins that respond to drugs and assays that already exist, which enables easy
investigation into treatment or analysis. There are well established fluoresced B and T cell
leukemic lines (Baeten et al., 2000).
Though zebrafish undergo hematopoiesis in their kidney marrow (deep kidney tissue)
and humans undergo hematopoiesis in their bones, T cell maturation occurs in the thymus of
both organisms. Furthermore, many transcription factors and signaling pathways for
differentiation of hematopoietic cells into their myeloid and lymphoid progenitors are very
similar, resulting in overlapping genetics and molecular biology in the development of leukemia
(Baeten et al., 2000). Recombination Activating Gene 2 (Rag2) is one such conserved gene across
human, mouse and zebrafish, that is present only in T and B lymphoid tissue, enabling specific
activation of transgenes that can induce leukemia in zebrafish (Langenau et al., 2004).
1

rag2:GFP-Myc Leukemia Producing Transgene
The Myc oncogene is conserved between zebrafish and their mammalian counterparts
in the expression of lymphocytic leukemia (O’Neil et al 2007), enabling experiment among an
established line of leukemic fish. In immature lymphocytes Recombination Activating Gene 2
(Rag2) plays a critical role in recombination, and a mutation of this gene affects the outcome for
VDJ recombination, impacting the later outcome of these cells (Weissman 1985, Schlissel, Kaffer
et al. 2006, Mijuskovic, Chou et al. 2015). Because the rag2 promoter for the rag2 gene is
specific to lymphocytes, the rag2 promoter can be hijacked to express Myc, inducing leukemia.
The line of zebrafish used in this study used transposase to create a double stranded break in
the zebrafish DNA in order to insert the mouse derived Myc transgene under the rag2 promoter
in order to limit the cancer to T and B lymphocytes (Langenau et al, 2003). Myc is fused with a
GFP gene in order to fluoresce (making the line rag2:GFP-Myc), which allows experimenters to
visualize, track and measure the leukemia in vivo. The particular line of fish in this experiment is
restricted to T lymphocytes only. Conversely, the control (nonleukemic) line is rag2:GFP
transgenic so the microenvironment without the influence of Myc can also be visualized.
Investigations into the activity of Myc under this (rag2) promoter are ongoing. Myc
affects growth at several points in the cell’s life cycle, including during double negative selection
into double positive selection, then again during stimulation of TCR, both of which occur in the
thymus (Delgado and Leon, 2010). The role of Myc is not limited to individual cell development
within the thymus, Myc is involved in cell migration and invasion in epithelial mesenchymal
layers (Wolfer and Ramaswamy, 2011). Furthermore, its role in solid tumor metastasis has been
well documented (Kortlever, Sodir et al., 2017). Contrary to solid tumors, in which spread of
metastasis indicates poorer prognosis, spread of lymphocytes into the periphery is common to
both leukemic and non- leukemic fish and impact on prognosis needs further investigation
(Stoletov, Montel et al., 2007). Overall, the molecular changes brought by rag2:GFP-Myc enable
a stable leukemic fish line.
Role of Vascular Endothelial Growth Factor in Immunity
During this maturation process, some cells will undergo clonal expansion, increasing the
odds that a cell with the correct antigen receptor will encounter the pathogen presenting the
2

reciprocating antigen (Hess et all 2012). In leukemic cells, the maturation process is mutated
between the selection processes, so propensity for cells to expand uncontrollably within and out
of the thymus is possible and this has been suggested as a means for leukemic cell dissemination
from the thymus (Feng et al. 2010)
We know that solid tumors remodel their local vascular environment in order to
transport nutrients and oxygen into the area, particularly through the use of VEGF to induce
angiogenesis (Kortlever et al 2017). Prior studies in mouse models indicate VEGF induced
microvasculature remodeling was also associated with leukocyte and mast cell recruitment
(Detmar et al 1998). In other forms of leukemia, particularly acute myeloid leukemia (AML) and
chronic lymphoblastic leukemia (CLL), plasma VEGF levels are markedly higher than in nonleukemic patients (Aguayo et al., 2000). The same study also found a relationship between
increased vascularization of the bone marrow, coinciding with increased VEGF expression and
poorer prognosis in AML and CLL patients (Aguayo et al., 2000). Using our zebrafish model, I will
be able to visualize leukemia progression in vivo, particularly as it relates to T cell dissemination
from the thymus to other areas of the fish’s body and identify what role VEGF may play in that
dissemination. I will be able to see patterns of vascular recruitment as VEGF changes the
microenvironment surrounding the thymus. This would not be possible in a mouse model
because of size constraints of the fluorescence microscope and depth of mouse tissue. A mouse
model would have to sacrificed and sectioned in order to be wholly observed. Fish have the
advantage of being small enough that their vasculature and organ systems can be imaged in
three dimensions while the animal is still alive.
Using the zebrafish model, we can elucidate the role VEGF plays in leukemia progression
and angiogenesis among endothelial (Fli1a), VEGFR-2 (Flk) and lymphatics (Lyve) fluorescently
tagged vasculature. While there are four kinds of VEGF (VEGF-A through VEGF-D) and three
receptors, the ones analyzed in this experiment will be VEGF-A and VEGFR-2, which regulates
angiogenesis and vascular permeability (Wang et al 2020). Additionally, VEGF expression can be
controlled in animals via heat shock promoter (hsp), to determine the role that VEGF plays in
leukemia progression. These fish with VEGF induction via heat shock promoter are also positive
for fluoresced Fli1a vasculature (Fli1a:RFP).
My hypothesis is that I will see an increase in VEGF-R vasculature (Flk) remodeling in
the local area surrounding the thymus in leukemic (rag2:GFP-Myc) fish, and I expect the vascular
3

density to increase as leukemia progresses, possibly providing routes for leukemic
dissemination. I also expect to see an increase in thymus volume as the leukemia progresses, in
keeping with suggestions by prior literature that leukemia expands within the thymus before
progression into the bloodstream. Furthermore, I expect that under increased VEGF protein
expression through use of a heat shock promoter, these features will be exacerbated in
leukemic (rag2:GFP-Myc), but not control (rag2:GFP), non-leukemic fish.
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Methods
Zebrafish Husbandry
All experimental procedures involving zebrafish were approved by the University of
Kentucky’s Institutional Animal Care and Use Committee, protocol number 2015-2225.
Transgenic lines used in this study are shown in Table 1. Animals were not excluded from
experiments based on sex and were between 13-30 days post-fertilization for these studies.
Light Sheet Fluorescence Microscopy
To prepare fish for imaging, each fish was anesthetized and then transferred to a 2 mL
microcentrifuge tube, removing excess water afterward. 300μL of 0.004% tricaine (MS-222,
Western Chemical Inc) in E3 media was added to each tube and fish were kept at rest for 5
minutes. 200 μL of a solution of 2% NuSieve GTG low-melt agarose (Lonza, cat. no. 50081) was
added to the tubes for a final agarose concentration of 0.8%. Tubes were mixed by inversion and
then the fish was loaded, tail first, into a glass capillary using a custom plunger (Zeiss). The
E3/agarose was then allowed to cool and solidify for five minutes. Agarose-constrained fish
were imaged using a Zeiss Light Sheet Z.1 dual-illumination microscope system and Zen imaging
software (ZEN 2014 SP1 Black Edition) at the University of Kentucky Arts & Sciences Imaging
Center. Fish ≤21 dpf were imaged into a Zeiss file, then converted to Imaris files. 20x objective
lens (P/N 421452-9700-000) and fish ≥21dpf were imaged with a Zeiss 5x objective lens (P/N
420330-8210-000).
To make E3: 14.6g NaCl, 0.65g KCl, 2.20g CaCl and 4.05g MgSO4 were combined in a 1L
bottle and topped off to 1L with ddH2O. The liquid made 50x concentration, which must be
diluted to a 1X concentration and buffered to pH=7. 50ul Methylene Blue (an antifungal) per 1L
of media was then added to yield the final 1X E3 media.
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Table 1. Zebrafish Lines Used
Zebrafish Line Name

Transgene

Expression Site

Flk:RFP

Tg(kdrl:RFP)

VEGFR+vasculature

Obtained From
ZIRC (Huang, Zhang et
al. 2005)
Laboratory of Protein

Fli1a:RFP

Tg(fli1a:RFP)

VEGFR- endothelial

Signaling and

vasculature

Interactions (Martin et
al, 2013)

Lyve:dsRED

Tg(-5.2Lyve1b:dsRED) Lymphatics

Rag2:GFP

Zrag2:GFP

Lymphocytes

Rag2:GFP-Myc

Zrag2:GFP-Myc

Lymphocytes/Leukemia

Crosier Lab (Okuda,
Astin et al. 2012)
Look Lab (Anderson, Li
et al. 2016)
Look Lab (Langenau,
Traver et al. 2003)
Mukhopadhyay

hsp:VEGF

h70-mC-hVEGF

Global

Lab (Hoeppner et al.,
2012)

Table 1: Zebrafish Lines: “zebrafish line name” indicates the shorthand name for the transgene
of interest, while “transgene” indicates the scientific nomenclature of the transgene. Expression
site indicates what will be fluoresced. “Obtained from” is the name of the lab of origin for the
transgene.
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Image Processing and Data Analysis
The images were analyzed using Imaris 9.2 (Bitplane) or FIJI. Files were converted to
.IMS files using Imaris File Converter 9.3.0. The Imaris surface creation software was used to
enhance the clarity of the rag2:GFP-Myc and rag2:GFP cells by applying a mask over all GFP+
cells. Images were saved as .tifs and GIMP photo editing software was used to de-convolute and
crop images.
For Volume: Using Imaris, the thymus volume was calculated by selecting the volume
tool and restricting the parameters to a box encompassing only the thymus. I selected the green
(GFP) field with a smoothness setting between 3 and 6. I completed the automated steps but
toggled the surfaces in the final step so only the thymus is selected, if multiple surfaces were
detected by the automated algorithm. The surface’s volume was then available to view under
the ‘statistics’ tab.
For measuring vascular density using Imaris, each thymus length was first measured in
pixels, then that length was doubled to create a region of interest that is proportional to the
thymus. The region of interest (ROI) was converted to μm by using Edit> image properties> ‘look
at x, y, z dimensions’ and then all axes’ pixel values were multiplied by their respective
conversion factor. The ROI was reported in μm3 and the percentage vascular density was
calculated by dividing the ROI vascular volume by the total ROI volume. Then I divided the sum
volume by the ROI and get a percent.
For measuring cell-vessel proximity using FIJI, all image stacks and channels were
adjusted for optimal signal:noise background reduction. Using the ‘points’ tool and ensuring
‘stack position’ was selected in the measurement options, cells were measured from the center
of their mass to the nearest vessel, whether that happened to be in plane or in a nearby plane.
30-50 cell-vessel measurements were made for each image volume included in this study. After
all points were reported, the values were moved to a spreadsheet, subtracted for all x-, y-, and
z-dimensions and then calculated using a simple, 3-dimensional, vector calculation between two
points. All calculated cell-vessel distances were averaged before reporting a value for each
animal, maintaining statistical independence of results.
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Cell Counts
In Imaris, a surface mask was used to ignore the GFP+ thymus in each image series.
Using the ‘spots’ tool, the GFP fluorescence channel was selected and then the diameter of a
cell was measured; then used as the estimated XY diameter. After the software has selected all
spots that meet the XY criteria, a manual deselection of cells in the thymus that were not
previously masked is carried out. From there, the cell count for each image can be copied from
the ‘statistics’ tab into a spreadsheet for further analysis.
RNA Isolation
Zebrafish bearing heat-shock promoter VEGF-A in the rag2:GFP-Myc genetic background
were raised until 21 dpf. Fish were separated into two groups, one remaining at 28°C and the
other to be maintained at 36°C for 3 days. Fish transferred to tanks for heat shock activation at
36°C were acclimated at 2°C increments daily until reaching 36°C. After 3 days of heat shock
treatment, all fish were sacrificed by placing in containers of aquarium water with lethal dosage
of tricaine supplemented prior to freezing in micro-centrifuge tubes on dry ice. All fish were
stored at -80°C until RNA isolation with TRIzol Reagent (Fisher Scientific, cat. no. 15596026).
After thawing, animals were disintegrated into 150 μL of TRIzol in a micro-centrifuge tube while
using a disposable pestle for each fish. After disintegration, 350 μL of TRIzol was added to each
tube, was mixed by flicking and inversion, with the remainder of the manufacturer’s protocol for
RNA isolation followed. Recovered RNA was quantified for each sample using Qubit RNA HS
Assay Kit (Fisher Scientific, cat. no. Q32852) and the Qubit 4 fluorometer system (Thermo
Fisher).
Reverse Transcription and qPCR
1 μg of RNA from each sample in the previous step was reverse transcribed using the
iScript cDNA synthesis kit (BioRad, cat. no. 1708891) and following the manufacturer’s
instructions. The list of primers used were as follows: vegfaa FWD: GAG CTG CTG GTA GAC ATC
ATC; vegfaa REV: TTC GAG CGC CTC ATC ATT AC; ef1a FWD: ATG GCA CGG TGA CAA CAT GCT;
ef1a REV: CCA CAT TAC CAC GAC GGA TG; rplp0 FWD: GCG TCC CTA CCG TGA GAT TTT; rplp0
REV: CGC CCA CGA TGA AAC ACT TG. qPCR samples were run in duplicate using iTaq Universal
SYBR Green Supermix (BioRad, cat. no. 1725121) in 96-well plates on C1000 Touch thermal
cycler (Bio-Rad) with standard, 2-step cycling parameters and 50°C annealing/extension. Results
8

were analyzed using comparative ΔCt analysis in spreadsheet software. Results were exported
to GraphPad Prism v7.04 and Mstat 6.6.2 (McArdle Laboratory, University of WisconsinMadison) for analysis and graphical representation of the results.
Statistical Analysis
For all multi-category comparisons, the Kruskal-Wallis (K-W) test was first used to
determine if any category’s values attained statistical significance from the other groups. For all
two-sample comparisons, the Mann-Whitney U(MWU)/Wilcoxon Rank Sum (WRS) statistical
tests were employed. C.I.’s were 0.95 and significance was defined as p≤0.05. Graphical
representations of data were generated in GraphPad Prism v7.04.
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Results
Leukemic Cell Dissemination Follows a Pattern
Using the fish in Figure 1A to orient ourselves to Figure 1B and 1E, we visualized the cell
dissemination, in leukemic fish (rag2:GFP-Myc), as it migrated from the thymus, caudally toward
the kidney head (Figure 1E). We saw that migration occured in a predictable, stepwise manner
and did not occur in the non- leukemic (rag2:GFP) fish. This is important because such a pattern
means the microenvironment surrounding the thymus (place of migration initiation) and along
the route of travel are being remodeled, perhaps in the same manner as solid tumors remodel
their local microenvironment in order to recruit vessels for nutrients and oxygen. While fish
younger than 14dpf did not appear to express leukemia regardless of Myc (or VEGF, as we will
get into) expression, by 21dpf, the leukemic fish (rag2:GFP-Myc) display a consistent exodus of
lymphocytes from the caudal tip of the medulla of the thymus that was not found in the nonleukemic (rag2:GFP) fish lines at any time period (Figure 1C). The dissemination direction was
significantly caudal in leukemic fish (rag2:GFP-Myc), with no particular direction of
dissemination in non-leukemic (rag2:GFP) fish (Figure 1D). Not only do more cells migrate
caudally, but a greater number of cells, overall, begin their journey (Figure 1C and 1D) among
the leukemic fish than among non-leukemic fish. I postulate that some cells will always be
present throughout the zebrafish, since lymphocytes are necessary responders to infection and
daily maintenance of the fish’s adaptive immunity, so non-leukemic cell dissemination will not
be zero.
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Figure 1: Leukemia Cell Dissemination

Figure 1: Leukemia Cell Dissemination: Using lightsheet microscopy and Imaris imaging
analysis, lymphocyte migration was calculated as lymphocytes left the thymus between
leukemic and non-leukemic fish with either a rag2:GFP (Wild Type) or rag2:GFP-Myc (leukemic)
cell marker.A) Animation for orientation of the fish. B) Representative images of cell
dissemination from the thymus displaying cell count significantly increased in rag2:GFP-Myc
(leukemic) fish compared to non- leukemic (rag2:GFP) fish. C) Significantly more cells migrate in
older leukemic (rag2:GFP-Myc) fish when compared to younger leukemic fish and non-leukemic
(rag2:GFP) at any age. (Solid line: p<0.05 dashed line: n.s.) D) Dissemination was also shown to
occur in a predictable pattern, with most cells exiting caudally with great significance in
Leukemic fish (rag2:GFP-Myc) (p<0.05), but pattern of dissemination was not significant (n.s.) in
non-leukemic (rag2:GFP) fish. E) The pattern of dissemination appears to migrate caudally,
toward the kidney head, seen in this graphic.
11

VEGF Heat Shock Increases Dissemination
As Figure 1C indicates, leukemic fish experienced greater cell dissemination than nonleukemic fish as the fish age. Since the effect can be induced in greater number under the VEGF
heat shock promoter (hspVEGF+) (Figure 2C) than without VEGF transgene (hspVEGF-) (Figure
2C), I can conclude the presence of VEGF protein provides a possible driver to heightened
leukemic dissemination, though other proteins, including the fish’s endogenous VEGF, which
appear to already be contributing to lymphocyte dissemination. The dissemination of
lymphocytes is simply lower in number prior to heat shock, and greater in number in fish that
possess the VEGF transgene. I speculate that since we see a similar uptick in dissemination
between among heat shocked fish with a VEGF transgene (hspVEGF+) and the RNA analysis
provided by the rtPCR data, the progression is at least in part driven by VEGF (Figure 2G). We
see increased lymphocyte spread from the thymus in the leukemic fish under the heat shock
than the control fish under the heat shock (Figures 2D, 2E and 2F). The spread is significantly
more caudal, but does have a non-significant, but trending dissemination dorsally as well (figure
2E). This implies that VEGF protein is certainly important to Leukemia trafficking, which is
consistent with previous research (Dias, 2000), though the specific mechanism needs further
exploration.
While the hspVEGF+ and hspVEGF- fish both experience significant cell migration
caudally, cells migrate en masse after a heat shock, at which time dorsal migration also becomes
significant in only the VEGF+ fish with the transgene (p<0.05) (Figure 2E). Heat shock induced
more cell exodus overall in the transgenic (VEGF+) fish, though the trend was slightly above a p
value of 0.05 (0.05<p<0.1). This indicates that an endogenous mechanism of cell migration may
be multifaceted but can be amplified with VEGF heat shock.
Since there is increased expression in VEGF protein expression and VEGF plays a role
in angiogenesis, this experiment wanted to assess the level of VEGF-Receptor (VEGFR)
expression in a selected area of the zebrafish. While levels of VEGFR do not bear significant
difference between leukemic and non-leukemic samples, a follow up real time PCR (Figure 2G)
indicated the VEGF protein was overexpressed in leukemic fish with a heat shock promoter after
the promoter was activated.
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Figure 2: Patterned Lymphocyte Migration
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Figure 2: Patterned Lymphocyte Migration: Using light sheet microscopy and Imaris imaging
analysis, the direction of lymphocyte migration was calculated as the lymphocytes left the
thymus. A) Leukemic (rag2:GFP-Myc) fish dissemination was most significant caudally (p<0.001
between caudal and all other directions). B) Non-leukemic (rag2:GFP) fish cell migration did not
have a significant direction of cell dissemination (n.s.). C) Overlay of heat shocked fish,
possessing the VEGF transgene (hspVegfA,rag2:GFP-Myc, flk:RFP) (blue), and without the
transgene(hspVegfA,rag2:GFP, flk:RFP) (grayscale,) showed an increase in caudal and rostral cell
dissemination for both transgenic and non-transgenic but the amount of cells migrating caudally
in the VEGF+ transgenic fish trends much greater than the VEGF- fish, without the transgene
after heat shock (0.05<p<0.1). D) Non-heat shocked VEGF+ fish (hspVegfA,rag2:GFP-Myc,
flk:RFP) began to undergo caudal cell migration at a significant rate when compared to ventral
and rostral directions (p<0.05 for both), with dorsal migration trending similarly (0.05<p<0.1). E)
Heat shocked VEGF+ (hspVegfA,rag2:GFP-Myc, flk:RFP) fish experienced significant cell
dissemination caudally, compared to ventral and rostral (p<0.05 both prior to and after heat
shock), but only after heat shock does dorsal migration become significant when compared to
ventral and rostral (p<0.05 for both). F) Caudal cell migration differences between transgenic
and non-transgenic fish indicated the greatest significance between the VEGF+ (transgenic) fish
after heat shock (p<0.01), but there was not significant difference between the VEGF+ and
VEGF- fish after heat shock, despite trending(0.05<p<0.1.), nor was there significance between
the non- transgenic VEGF- before and after heat shock (n.s.) G qPCR quantification 9derived
from cDNA made from RNA) of VEGF gene expression validated significant uptick in expression
of the VEGF gene after the heat shock, but the same significance did not exist in the fish lacking
the VEGF gene (p<0.05)
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No Significant Evidence of Vascular Remodeling
The second point to my hypothesis was that as leukemia expands outward from the
thymus, it would recruit and remodel the vasculature of the local environment. Vessel density
among leukemia positive specimens is of interest because tumorous tissue develops in hypoxic
niches. This experiment sought to assess the role of vessel formation in leukemia to see if it was
similar to that found in solid tumors. Looking at fish with red fluoresced lymphatics (Figure 3A
and 3B), general endothelial (Figure 3C and 3D) and endothelial vasculature bearing a VEGFreceptor marker (Figure 3E and 3F), I compared leukemic and non-leukemic fish to see if the
vascular density in the area surrounding the thymus was being remodeled. Fundamentally, I was
treating the thymus like a solid tumor. Additionally, I looked at co-localization between leukemic
cells and their vasculature by quantifying their overlap (Figure 3G).
I saw no evidence of co-localization between any vessel line and the lymphocytes
(Figure 3G). In analyzing a region of interest twice the length of the thymus all the way around
(and limited to the boundaries within the fish itself) I saw that vascular change during leukemic
progression was not quite significant among any vessel type. Figures 3A,3B and 3C show that no
matter the vasculature type, the vessel density within the region of interest was not significantly
remodeled when compared to the control of the same vessel type. In fact, vessel densities
varied widely between animals. Flk is vasculature bearing a VEGF receptor (VEGFR) (Figure 3C
and 3D). I was expecting the Flk (VEGFR+) vasculature to undergo the most remodeling, since we
understand that VEGF presence creates the optimum environment to increase leukemia
dissemination, but as Figure 3D shows, the vessel density of VEGFR-2 tagged vasculature (Flk) is
not significantly changed during leukemia migration. This allows us to conclude that unlike solid
tumor formation, VEGF is not playing a role in angiogenesis and vasculature remodeling in
leukemic zebrafish; it might be playing a different role, which needs further research.
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Figure 3: Vessel Density and Distance

16

Figure 3: Vessel Density and Distance: Using light sheet microscopy and Imaris imaging analysis,
a region of interest surrounding the thymus was taken. The percent of the ROI taken up by
vessels was calculated and compared between Leukemic (rag2:GFP-Myc) and non-leukemic
(rag2:GFP) fish. A) Representative imagery of Lymphatics (Lyve:RFP) vasculature with B) graphic
analysis of lymphatics vasculature (n.s.).C) Representative imagery of VEGFR+ vasculature with
D) graphic analysis of VEGFR+ vasculature (n.s.). E) Representative imagery of Endothelial
(Fli1a:RFP) vasculature with F)Graphic analysis of endothelial vasculature (Fli1a:RFP) (n.s.). G)
Graphic analysis of co-localization was achieved using FIJI imaging software, in which colocalization of the vessels (red) and the leukemic cells (green) would have been represented in
yellow, which indicated leukemic cells are not significantly close to any vasculature as (see
figures 2A, 2C and 2C) (n.s.).
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Thymus Volume Does Not Induce Leukemic Dissemination
Initially I hypothesized that as leukemia progressed, I would see an increase in thymus
volume but the increase in thymus volume did not appear to associate significantly with
leukemia progression (Figure 4). Any difference in volume could be attributed to age, which is
why we see such large ranges for each subtype in Figure 4. There was a difference in thymus
volume between 14dpf fish and 28 dpf fish within the same subgroup (within just leukemic fish
for example), but there was no significant difference between the thymus volume of control and
leukemic fish. This runs contrary to the current knowledge that leukemogenesis may evolve
from a single cell dividing in the thymus into a mass of leukemic cells that push the thymic
boundaries and enter the interstitial space (Hess et al., 2012). If that were the case, I would see
random selection as regards to which side of the thymus experienced eruption of the leukemic
cells first, but as previously explored in Figure 1 and 2, the data indicates that leukemia
progression is largely predictable.
It can be noted that the Fli thymus volume has a p value that is very close to being
significant (0.05<p<0.1). This is important because Fli vasculature do not wholly overlap with
VEGF-R tagged (Flk) vasculature, so the driver of this trend may be something other than VEGF
entirely. Further investigation is needed.
Not surprisingly, our VEGF heat shock experiment (hspVEGF) follows the trends set by
the fli, flk and lyve assessments of thymus volumes. Looking at Figure 4D we see no significance
in the volume of the thymus whether leukemic or control after heat shock. While both the
leukemic and control experienced a change in thymus size due to the heat itself, the difference
between them is non-significant and implies that VEGF did not play a role in inducing the
thymus volume change.
Figure 4a represents the reality of what I see when I analyze and process the
fluorescence imagery. Not only do we see how the leukemic cells exit caudally from the thymus,
we see in 4b that no cells overlap or travel along any vasculature type. Since the thymocytes are
green fluoresced and the vessels are red fluoresced, overlap will appear as yellow fluorescence
(this is done automatically during imaging), but no such overlap occurs. This contests the theory
of migration along vessels that had previously been established (Langenau et al., 2003)
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Thymus volume appears to increase in size regardless of whether the fish has the VEGF
gene or does not have it. The presence of VEGF does not appear to enable a significant
difference in thymus size; the heat shock alone appears to be the contributing factor. Between
VEGF+28 and VEGF+ 36 p<0.05, and between VEGF-28 and VEGF-36 p<0.01, indicating it is
significant regardless, only heat matters. There is no significant change in size when both VEGFand VEGF+ are at 28 Celsius and no difference between VEGF- and VEGF+ at 36 Celsius either.
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Figure 4: Thymus Volume

Figure 4: Thymus Volume: Using light sheet microscopy and Imaris imaging analysis, the thymus
volume was calculated in its entirety between non-leukemic (rag2:GFP) and leukemic (rag2:GFPMyc) fish with a A) Fli1a:RFP endothelial cell marker, B) Flk:RFP VEGF-receptor marker, C)
Lyve:RFP Lymphatics marker and D) Heat shocked VEGF marker. There was no significance
between the leukemic and non-leukemic thymuses in any line. P>0.05 for all (n.s.).
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Discussion
Using a well-established line of zebrafish bearing Myc-induced T-cell leukemia
(Langenau, Traver et al. 2003), we visualize the initial expansion of leukemia from the thymus in
the context of the vascular microenvironment and enhanced VEGF expression. I compared these
rag2:GFP-Myc transgenic, (leukemic) fish to a rag2:GFP control (non- leukemic) model. Both fish
lines were outcrossed to a Casper strain, which is a mutation of the mitfa gene that causes a
complete lack of melanocytes, so the fish’s scales are somewhat transparent (White, Sessa et al.
2008). This allowed me to better visualize the fluorescence via light sheet microscopy. With the
goal of understanding the role of Vascular Endothelial Growth Factor in angiogenesis during
leukemogenesis, I identified a step-wise onset of leukemic cell migration from the caudal tip of
the thymus (Figure 1 and Figure 2). Leukemia progression was not associated with any vascular
remodeling, and leukemia cells did not migrate along particular vascular tracks (Figure 3).
Leukemia progression was not associate with any change in thymus size, which contests earlier
studies that the reason for sudden cell migration was that clonal expansion within the thymus
breeched the limits of the thymus (Hess et al.,2012). However, VEGF significantly accelerated
leukemia progression from the caudal tip of the thymus along a predictable path toward the
kidney head, indicating that VEGF may be acting as a signaling molecule directly impacting
leukemia cells (Figure 2).
Our means of zebrafish husbandry required successive generations of pairing from Myc
positive fish, which means that the onset of leukemia had to be later, with slow leukemia
formation and spread, as the animals are maintained in a manner that enables them to reach
breeding age. This may mean that my study does not have good representation of acute
lymphoblastic leukemia, which would likely have killed afflicted fish prior to making it to
adulthood. This slow progression bears a resemblance to chronic lymphocytic leukemia in
mammals (Finola et al, 2012). The spread into the caudal area proximal to the thymus and
kidney head is consistent with prior literature (Finola et al, 2012, Blackburn et al 2012). I chose
to examine the microenvironment surrounding the thymus because the pattern leukemic fish
undergo during cell dissemination was relatively linear(Figures 1 and 2) and I likened the thymus
to a solid tumor and observed to see if it, or the leukemic cells that composed it, would remodel
their surroundings in the same way.
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I looked at lymphatic (Lyve), all endothelial (Fli1a) and VEGFR-tagged endothelial
vasculature, though if I had been more thorough I would have analyzed other linear tissue, (such
as neural tissue) but I will explore the latter briefly. The direction of cell migration does not
appear to be influenced by any endothelial or lymphatics vasculature (Figure 3). This contrasts
findings of earlier studies that indicate in acute lymphoblastic leukemia cells, which show an
initial random migration of leukemic cells from the thymus, followed by travel along blood
vessels to the kidney head (Langenau, Traver et al 2003). I further analyzed co-localization of
cells and vasculature, looking for overlap, but did not find any significance (Figure 3G).
While I did not observe T-cells following along any vasculature, it is important to note
that the zebrafish used in this study were F2 generation as opposed to the F0 generation in the
Langenau study, which means the onset of leukemia had to be slower to enable successive
generations and thus maybe more akin to chronic lymphoblastic leukemia (CLL) than the acute
lymphoblastic leukemia (ALL) that appear in previous studies. The path of dissemination may
vary for this reason. Of course, it is possible that since ALL is so acute, patterns of dissemination
are difficult to track and the slow progression in my experiment allows time for tracking subtlety
that would otherwise be missed. Variance from the previous study may also be the result of an
amplifying, synergistic effect between the endogenous myc of the zebrafish and its mouse
derived Myc transgene. Having two copies of the gene might influence leukemic progression.
Nevertheless, the ultimate dissemination pattern resulted in the same destination for the
lymphocytes as mentioned in previous literature; caudal migration appears to be heading
toward the kidney (Figures 1 and 2).
Dorsal migration also appears to have some significance, though to a much less
significant degree than caudal migration (Figure 2E). This may be due to my own imperfect
measuring the sections of the fish. Looking at Figure 1B and 1E cell dissemination is in a
somewhat dorsal-caudal pattern, but in my to avoid counting the same cells twice, I had to
make a very hard cut off for what qualified as dorsal and what qualified as caudal. I could have
simply divided the fish into caudal and rostral halves, but four directions more accurately
represented a three-dimensional animal. Nonetheless, whether the path of dissemination is
distinctly caudal or somewhat dorsal, vessels were not the tract along which the cells were
traveling (Figure 3G).
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If vessels are not the track leukemic cells follow, I speculated that something else about
the thymus might induce the leukemic migration. Keeping with the theory that T-cell clonal
expansion was the culprit, I observed the thymus volume. I found the thymus increased in size
significantly whether the fish had leukemia or not (Figure 4). It seemed increase in thymus
volume was a function of growth over time. It is worth noting the Fli1a fish line was very close
to significance, but it fell short. It could be anomalous, or there could be an increase in the
thymus of those Fli1a fish, but perhaps more research is needed.
With vascular remodeling and changes to the thymus not fully explaining what
summoned the thymocytes from the thymus, there may be some kind of chemoattractant
gradient stemming from an unseen source that I have not yet measured. Studies in mice identify
VEGF receptor (VEGF) on the surface of leukemic cells. Furthermore, increased human VEGF
protein appears in mice xenografted with human leukemia (Dias et al., 2000). Murine Vegf is not
elevated in these xenografted mice, indicating that it is the leukemic cells, themselves, that are
the potential producer of the human VEGF protein, which may be acting in a paracrine or
autocrine manner (Dias et al, 2000). The leukemia is potentially releasing VEGF protein, which in
turn acts on either the cell itself or its neighboring cells. If I apply this logic to my experiment, its
possible that leukemic cell migration is activated by the leukemia at a certain time, since we see
that the en masse migration begins in older rag2:GFP-Myc fish (Figure 1C). This migration might
be induced by the first cell(s) to turn on VEGF, which would explain why we see so much more
dissemination caudally under a heat shock promoter for Vegf (Figure 2). During the heat shock
experiment I noticed that lymphocyte migration did not begin en masse until after the heat
shock (Figure 2F) when VEGF expression is upregulated (Figure 2G); it did not occur with any
significance in the heat shocked control fish (Figure 2F). Increased intracellular VEGF expression
is associated with poorer prognosis in chronic lymphoblastic leukemia and CLL was also found to
have no significant change to the vasculature (Aguayo et al. , 2000). This supports my
postulation that it is the leukemia itself using VEGF as a signal to migrate en masse. Investigation
into why it migrates in such a linear fashion from the caudal tip of the thymus toward the kidney
head needs further investigation.
Future Directions
Paracrine and autocrine signaling do not fully explain why the leukemic cells travel en
masse along the same route of dissemination from the caudal tip of the thymus toward the
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kidney head. If the leukemia is acting in a paracrine or autocrine manner, it could be activated at
any place within the thymus and therefore disseminate from all sides. Non-leukemic fish
experienced random dissemination patterns (Figure 2B), so it stands to reason that the
thymocyte passage through the thymus cortex to medulla for maturation is not responsible for
the caudal exodus point. It should be noted that leukemic cells are abnormal, so further
investigation is needed to rule this out. I cannot rule out the kidney head as the
chemoattractant secreting organ, but since the path of dissemination was limited only to the
side of the organ proximal to the thymus, I propose its worth looking at what is special about
what is between the two organs. Since the route between thymus and kidney head is such a
linear tract, it is worth examining linear tracts of tissue. Since I have ruled out lymphatics and
endothelial vasculature, including endothelial vasculature bearing the VEGF receptor, it might be
worth looking into nervous tissue. Nervous tissue have linear tracts and the kidney head is
highly innervated.
Looking at pathologies across central nervous tissue VEGF has been shown to be
upregulated when cerebellar granule neurons (and astrocytes, to a lesser degree) are subjected
to slightly hypoxic conditions. The study found the presence of VEGF bound to its receptor
provided protection to the local neurons, but when unbound that protection is lost, further
supporting the paracrine/autocrine hypothesis (Wick et al., 2002). Hypoxic tumors are also
known to secrete VEGF in order to promote vascularization of the tumor in order to deliver
oxygen and nutrients as the tumor expands (Casey et al., 2015). From this I might speculate that
hypoxia could be playing a role to induce the VEGF signaling in leukemia, but further
investigation is needed.
Previous studies on the effects of double stranded breaks and faulty repair mechanisms
in Rag2:Myc murine model indicate that not only does V(D)J recombination enable
leukemogenesis in lymphocyte progenitors, but also that there is a high incidence of
comorbidity with severe neural pathology. While this study analyzed the phenomena in pro-B
cell leukemia, it compared its findings to leptomeningeal leukemia and terminal acute
lymphoblastic leukemia (Gladdy et al., 2003). Patients experience a poorer prognosis once the
leukemia spreads to the central nervous system. Future research might elucidate the role
hypoxic neurons might play in VEGF signaling. There may be a link to the leukemia trafficking we
have seen, but I will have to look at hypoxia, VEGF levels and fluorescently tagged neurons.
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Limitations of Experiment
One of the shortcomings in this set of experiments is the limitation on the number of
animals included. While more than 50 animals were studied, significance could be vastly
improved upon with more animals at specific age brackets, and more per fish line. In fact, the Fli
vessel density was trending very close to significance that analysis of 5 or 10 more fish may have
been able to slide the significance to be more representative of the reality. Animal studies are
limited by time constraints. This study also had to contend with the fact that the microscopy and
RNA extractions were terminal for all the fish.
In conclusion, consistent, predictable trafficking among rag2:GFP-Myc induced leukemia
may be the result of some kind of microenvironment change that is influenced by VEGF. The
trafficking does not appear related to nearby endothelial (including VEGFR-tagged) vasculature
or lymphatics, but investigation into the roles of neuron VEGF secretion and hypoxia is needed
as the trafficking is linear and predictable. I now hypothesize that VEGF protein and VEGFRreceptor are acting together in a paracrine/autocrine manner. The role of zebrafish as a model
for leukemia can be further explored with further focus on other linear tissues, such as neuronal
and more focus on molecular mechanisms in those tissues, particularly in adult fish, whose
leukemia may be more akin to chronic lymphoblastic leukemia. Understanding these
mechanisms may provide therapeutic drug targets that could be modified to benefit human
patients.
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